Maraskovsky; Eugene
Patent Applications and Registrations
Patent applications and USPTO patent grants for Maraskovsky; Eugene.The latest application filed is for "method of treating cancer".
Company Profile
6.20.28
- Maraskovsky; Eugene - Kew AU
- MARASKOVSKY; Eugene - Parkville AU
- - Parkville AU
- Maraskovsky; Eugene - Victoria AU
- Maraskovsky; Eugene - Seattle WA
- Maraskovsky; Eugene - Caulfield Nth AU
- Maraskovsky, Eugene - Caulfied Nth AU
Patent Activity
| Patent | Date |
|---|---|
| Modulation of FVIII immunogenicity by truncated VWF Grant 11,141,466 - Verhagen , et al. October 12, 2 | 2021-10-12 |
| Method Of Treating Cancer App 20210292411 - BEHREN; Andreas ; et al. | 2021-09-23 |
| Anti-tumor Compositions And Uses Thereof App 20210252136 - BAZMORELLI; Adriana ; et al. | 2021-08-19 |
| Modulation Of Fviii Immunogenicity By Truncated Vwf App 20200197495 - VERHAGEN; Anne ; et al. | 2020-06-25 |
| Financial Method App 20200030440 - BAZMORELLI; Adriana ; et al. | 2020-01-30 |
| Method Of Treating Cancer App 20190023783 - BEHREN; Andreas ; et al. | 2019-01-24 |
| Compositions and methods for targeting type 1 interferon producing cells Grant 9,758,585 - Vairo , et al. September 12, 2 | 2017-09-12 |
| Anti-tumor Compositions And Uses Thereof App 20170014507 - Bazmorelli; Adriana ; et al. | 2017-01-19 |
| Method Of Treating Cancer App 20160376364 - BEHREN; Andreas ; et al. | 2016-12-29 |
| Treatment of neurological conditions Grant 9,364,534 - McKenzie , et al. June 14, 2 | 2016-06-14 |
| Treatment of neurological conditions Grant 9,352,038 - McKenzie , et al. May 31, 2 | 2016-05-31 |
| Method of treating inflammatory bowel disease Grant 9,211,329 - McKenzie , et al. December 15, 2 | 2015-12-15 |
| Compositions And Methods For Targeting Type 1 Interferon Producing Cells App 20150147322 - VAIRO; Gino Luigi ; et al. | 2015-05-28 |
| Anti-tumor Compositions And Uses Thereof App 20150037374 - BAZMORELLI; Adriana ; et al. | 2015-02-05 |
| Immunotherapeutic method involving CD123 (IL-3Rα) antibodies and immunostimulating complex Grant 08920803 - | 2014-12-30 |
| Immunotherapeutic method involving CD123 (IL-3R.alpha.) antibodies and immunostimulating complex Grant 8,920,803 - Drane , et al. December 30, 2 | 2014-12-30 |
| Treatment Of Neurological Conditions App 20140234303 - McKenzie; Brent Steven ; et al. | 2014-08-21 |
| Compositions And Methods For Targeting Type 1 Interferon Producing Cells App 20140178364 - VAIRO; Gino Luigi ; et al. | 2014-06-26 |
| Receptor activator of NF-kappaB Grant 8,569,456 - Anderson , et al. October 29, 2 | 2013-10-29 |
| Methods of treating lupus by administering humanized anti-interleukin 3 receptor alpha chain antibodies Grant 8,535,669 - Vairo , et al. September 17, 2 | 2013-09-17 |
| Method Of Treating Inflammatory Bowel Disease App 20130164291 - MCKENZIE; Brent ; et al. | 2013-06-27 |
| IMMUNOTHERAPEUTIC METHOD INVOLVING CD123 (IL-3Ra) ANTIBODIES AND IMMUNOSTIMULATING COMPLEX App 20130149303 - Drane; Debra Pauline ; et al. | 2013-06-13 |
| Compositions And Methods For Targeting Type 1 Interferon Producing Cells App 20130084282 - Vairo; Gino Luigi ; et al. | 2013-04-04 |
| RECEPTOR ACTIVATOR OF NF-kappaB App 20120178912 - ANDERSON; Dirk M. ; et al. | 2012-07-12 |
| Treatment Of Neurological Conditions App 20110091456 - McKenzie; Brent Steven ; et al. | 2011-04-21 |
| Method For Modifying Celluar Immune Resonse By Modulating Activin Activity App 20100279409 - Robson; Neil ; et al. | 2010-11-04 |
| Dendritic cell stimulatory factor App 20090075886 - BRASEL; Kenneth ; et al. | 2009-03-19 |
| Methods of preparing dendritic cells with flt3-ligand and antigen Grant 7,150,992 - Lynch , et al. December 19, 2 | 2006-12-19 |
| Use of flt3-ligand in the treatment of infection App 20040037845 - Brasel, Kenneth ; et al. | 2004-02-26 |
| Method for enhancing the functional capacity of dendritic cells Grant 6,649,164 - Maraskovsky November 18, 2 | 2003-11-18 |
| Receptor activator of NF-kappaB App 20030175840 - Anderson, Dirk M. ; et al. | 2003-09-18 |
| Method of activating dendritic cells App 20030077263 - Maraskovsky, Eugene ; et al. | 2003-04-24 |
| Receptor activator of NF-.kappa.B Grant 6,537,763 - Dougall , et al. March 25, 2 | 2003-03-25 |
| Receptor activator of NF-.kappa.B Grant 6,528,482 - Anderson , et al. March 4, 2 | 2003-03-04 |
| Method of stimulating an immune response with activated dendritic cells Grant 6,497,876 - Maraskovsky , et al. December 24, 2 | 2002-12-24 |
| Ligand for receptor activator of NF-kappaB App 20020169117 - Maraskovsky, Eugene | 2002-11-14 |
| Receptor activator of NF-.kappa.B Grant 6,479,635 - Anderson , et al. November 12, 2 | 2002-11-12 |
| Antibodies against ligand for receptor activator of NF-kB App 20020086826 - Anderson, Dirk M. ; et al. | 2002-07-04 |
| Receptor activator of NF-kappaB App 20020081720 - Dougall, William C. ; et al. | 2002-06-27 |
| Dendritic Cell Stimulatory Factor App 20020034517 - BRASEL, KENNETH ; et al. | 2002-03-21 |
| Receptor activator of NF-.kappa.B Grant 6,017,729 - Anderson , et al. January 25, 2 | 2000-01-25 |
| Activated dendritic cells and methods for their activation Grant 6,017,527 - Maraskovsky , et al. January 25, 2 | 2000-01-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 